Penfill and hepatic function abnormal Patient Reports February 13, 2012

Penfill Side Effects Report #4944171-7
Penfill side effect was reported by a Physician from JAPAN on Mar 06, 2006. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with ketoacidosis and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Penfill dosage: unknown. During the same period patient was treated with PENFILL N CHU, NOVORAPID CHU, LANTUS. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #4582515-9
Penfill side effect was reported by a Physician from on Feb 03, 2005. Male patient, 58 years of age, weighting 112.4 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Penfill. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Penfill dosage: unknown. During the same period patient was treated with KINEDAK, GLIMICRON. Patient was hospitalized. Patient recovered.

Penfill Side Effects Report #5788726-9
Penfill side effect was reported by a Physician from JAPAN on June 16, 2008. Female patient, 57 years of age, was diagnosed with hyperglycaemia and was treated with Penfill. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Penfill dosage: unknown. During the same period patient was treated with PENFILL R CHU, HUMALOG, HUMACART N, FLOMOX, CEFACLOR. Patient recovered.